These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 8043585

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Stabilizing a flexible interdomain hinge region harboring the SMB binding site drives uPAR into its closed conformation.
    Zhao B, Gandhi S, Yuan C, Luo Z, Li R, Gårdsvoll H, de Lorenzi V, Sidenius N, Huang M, Ploug M.
    J Mol Biol; 2015 Mar 27; 427(6 Pt B):1389-1403. PubMed ID: 25659907
    [Abstract] [Full Text] [Related]

  • 24. Pericellular proteolysis by leukocytes and tumor cells on substrates: focal activation and the role of urokinase-type plasminogen activator.
    Kindzelskii AL, Amhad I, Keller D, Zhou MJ, Haugland RP, Garni-Wagner BA, Gyetko MR, Todd RF, Petty HR.
    Histochem Cell Biol; 2004 Apr 27; 121(4):299-310. PubMed ID: 15042374
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.
    Czekay RP, Kuemmel TA, Orlando RA, Farquhar MG.
    Mol Biol Cell; 2001 May 27; 12(5):1467-79. PubMed ID: 11359936
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
    Vines DJ, Lee SW, Dichek DA, Ellis V.
    J Pept Sci; 2000 Sep 27; 6(9):432-9. PubMed ID: 11016879
    [Abstract] [Full Text] [Related]

  • 31. Structural analysis of the interaction between urokinase-type plasminogen activator and its receptor: a potential target for anti-invasive cancer therapy.
    Ploug M, Gårdsvoll H, Jørgensen TJ, Lønborg Hansen L, Danø K.
    Biochem Soc Trans; 2002 Apr 27; 30(2):177-83. PubMed ID: 12023847
    [Abstract] [Full Text] [Related]

  • 32. Structure-function relationships in the interaction between the urokinase-type plasminogen activator and its receptor.
    Ploug M.
    Curr Pharm Des; 2003 Apr 27; 9(19):1499-528. PubMed ID: 12871065
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms.
    Stepanova V, Mukhina S, Köhler E, Resink TJ, Erne P, Tkachuk VA.
    Mol Cell Biochem; 1999 May 27; 195(1-2):199-206. PubMed ID: 10395084
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function.
    Fischer K, Lutz V, Wilhelm O, Schmitt M, Graeff H, Heiss P, Nishiguchi T, Harbeck N, Kessler H, Luther T, Magdolen V, Reuning U.
    FEBS Lett; 1998 Oct 30; 438(1-2):101-5. PubMed ID: 9821967
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Cell-surface acceleration of urokinase-catalyzed receptor cleavage.
    Høyer-Hansen G, Ploug M, Behrendt N, Rønne E, Danø K.
    Eur J Biochem; 1997 Jan 15; 243(1-2):21-6. PubMed ID: 9030717
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.